PPARA and metabolic dysfunction-associated steatotic liver disease: In NAFLD subjects, the expression of hepatic PPARα is decreased, and mice models with PPARα deletion show a high accumulation of triglycerides [92], confirming an involvement of PPARα in NAFLD and NASH progression.